1. Home
  2. CRL

CRL

Charles River Laboratories International Inc.

Logo Charles River Laboratories International Inc.

Health Care

Biotechnology: Commercial Physical & Biological Resarch

Nasdaq

as 04-23-2024 12:30pm EST

$
-
-
-
.
-
-
+$
-
.
-
-
+
-
.
-
-
%

Charles River Laboratories was founded in 1947 and is a leading provider of drug discovery and development services. The company's research model & services segment is the leading provider of animal models for laboratory testing, which breeds and delivers animal research models with specific genetic characteristics for preclinical studies around the world. The discovery & safety assessment segment includes services required to take a drug through the early development process, including discovery services. The manufacturing support segment includes microbial solutions, which provides in vitro (non-animal) testing products, biologics testing services, and avian vaccine services.

Founded: N/A Country:
United States
United States
Employees: N/A City: WILMINGTON
Market Cap: 11.9B IPO Year: 2000
Target Price: $257.45 AVG Volume (30 days): 529.3K
Analyst Decision: Buy Number of Analysts: 12
Dividend Yield: N/A Dividend Payout Frequency: N/A
EPS: 9.22 EPS Growth: -2.74
52 Week Low/High: $161.65 - $275.00 Next Earning Date: 05-09-2024
Revenue: $4,129,409,000 Revenue Growth: 3.86%
Revenue Growth (this year): 3.21% Revenue Growth (next year): 7.37%

Share on Social Networks:

Stock Insider Trading Activity of Charles River Laboratories International Inc. (CRL)

Name Ticker Relationship Date Transaction Cost Per Share Shares Total Value Securities Owned After Transaction(s) SEC Form 4
Creamer Victoria L CRL EVP & Chief People Officer Feb 29 '24 Sell $253.70 5,000 $1,268,500.00 13,550 SEC Form 4
LaPlume Joseph W CRL EVP, Corp Strategy & Develop Nov 30 '23 Sell $197.73 1,850 $365,800.50 23,133 SEC Form 4